These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 18279216

  • 1. Efficacy of fluticasone metered-dose inhaler and dry powder inhaler for pediatric asthma.
    Miyahara H, Korematsu S, Nagakura T, Izumi T.
    Pediatr Int; 2008 Feb; 50(1):103-8. PubMed ID: 18279216
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of mometasone furoate dry powder inhaler vs fluticasone propionate metered-dose inhaler in asthma subjects previously using fluticasone propionate.
    Wardlaw A, Larivee P, Eller J, Cockcroft DW, Ghaly L, Harris AG.
    Ann Allergy Asthma Immunol; 2004 Jul; 93(1):49-55. PubMed ID: 15281471
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of salmeterol/fluticasone propionate delivered via a hydrofluoroalkane metered dose inhaler in Chinese patients with moderate asthma poorly controlled with inhaled corticosteroids.
    You-Ning L, Humphries M, Du X, Wang L, Jiang J.
    Int J Clin Pract; 2005 Jul; 59(7):754-9. PubMed ID: 15963199
    [Abstract] [Full Text] [Related]

  • 4. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
    Murphy K, Noonan M, Silkoff PE, Uryniak T.
    Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
    [Abstract] [Full Text] [Related]

  • 5. Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients.
    Busse WW, Shah SR, Somerville L, Parasuraman B, Martin P, Goldman M.
    J Allergy Clin Immunol; 2008 Jun; 121(6):1407-14, 1414.e1-6. PubMed ID: 18455221
    [Abstract] [Full Text] [Related]

  • 6. Concurrent use of metered-dose and dry powder inhalers by children with persistent asthma does not adversely affect spacer/inhaler technique.
    Chan DS, Callahan CW, Hatch-Pigott VB, Lawless A, Proffitt HL, Manning NE, Schweikert MP.
    Ann Pharmacother; 2006 Oct; 40(10):1743-6. PubMed ID: 16968822
    [Abstract] [Full Text] [Related]

  • 7. Metered dose inhaler with spacer versus dry powder inhaler for delivery of salbutamol in acute exacerbations of asthma: a randomized controlled trial.
    Lodha R, Gupta G, Baruah BP, Nagpal R, Kabra SK.
    Indian Pediatr; 2004 Jan; 41(1):15-20. PubMed ID: 14767083
    [Abstract] [Full Text] [Related]

  • 8. Fluticasone propionate plasma concentration and systemic effect: effect of delivery device and duration of administration.
    Whelan GJ, Blumer JL, Martin RJ, Szefler SJ, Asthma Clinical Research Network and the Pediatric Pharmacology Research Unit Network.
    J Allergy Clin Immunol; 2005 Sep; 116(3):525-30. PubMed ID: 16159619
    [Abstract] [Full Text] [Related]

  • 9. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM.
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of a 12-week therapy with a new formulation of fluticasone propionate at doses of 125 and 250 μg administered through a new generation cyclohaler twice daily, in comparison to fluticasone propionate 500 μg dry powder inhaler twice daily in patients with moderate asthma.
    Kupryś-Lipińska I, Tworek D, Vanderbist F, Bocheńska-Marciniak M, Kuna P.
    Pneumonol Alergol Pol; 2013 Jul; 81(6):527-36. PubMed ID: 24142782
    [Abstract] [Full Text] [Related]

  • 11. [Peak inspiratory flow generated through different analogue dry powder inhalers in Shenzhen healthy preschool children].
    Zhang QL, Zheng JP, Pan WH, He H, Chen GL, An JY, Yuan LF, Luo DF.
    Zhonghua Er Ke Za Zhi; 2008 Feb; 46(2):98-103. PubMed ID: 19099680
    [Abstract] [Full Text] [Related]

  • 12. Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids.
    Hampel FC, Martin P, Mezzanotte WS.
    J Asthma; 2008 May; 45(4):265-72. PubMed ID: 18446589
    [Abstract] [Full Text] [Related]

  • 13. Comparison of mometasone furoate dry powder inhaler and fluticasone propionate dry powder inhaler in patients with moderate to severe persistent asthma requiring high-dose inhaled corticosteroid therapy: findings from a noninferiority trial.
    Harnest U, Price D, Howes T, Sussman G.
    J Asthma; 2008 Apr; 45(3):215-20. PubMed ID: 18415829
    [Abstract] [Full Text] [Related]

  • 14. A new formulation of fluticasone propionate/salmeterol in a metered-dose inhaler (MDI HFA) allows for the reduction of a daily dose of corticosteroid and provides optimal asthma control - A randomized, multi-center, non-inferiority, phase IV clinical study.
    Kupczyk M, Majak P, Kuna P, Asankowicz-Bargiel B, Barańska E, Dobek R, Garbicz S, Jerzyńska J, Latos A, Machowiak W, Majorek-Olechowska B, Olech-Cudzik A, Poziomkowska-Gęsicka I, Rulewicz-Warniełło M, Świderska A, Tarnowski M, Kopyto P.
    Respir Med; 2021 Jan; 176():106274. PubMed ID: 33276251
    [Abstract] [Full Text] [Related]

  • 15. Fluticasone propionate HFA-134a pressurized metered-dose inhaler in adolescents and adults with moderate to severe asthma.
    Pinnas JL, Noonan MJ, Weinstein SF, Chervinsky P, Scott CA, Herje NE, Wu W, Crim C.
    J Asthma; 2005 Dec; 42(10):865-71. PubMed ID: 16393726
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetic Comparison of a Unit Dose Dry Powder Inhaler with a Multidose Dry Powder Inhaler for Delivery of Fluticasone Furoate.
    Mehta R, Moore A, Riddell K, Joshi S, Chan R.
    J Aerosol Med Pulm Drug Deliv; 2017 Oct; 30(5):332-338. PubMed ID: 28463040
    [Abstract] [Full Text] [Related]

  • 17. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.
    O'Connor RD, Patrick DL, Parasuraman B, Martin P, Goldman M.
    J Asthma; 2010 Mar; 47(2):217-23. PubMed ID: 20170333
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of fluticasone propionate multidose, inhalation-driven, novel, dry powder inhaler versus a prevailing dry powder inhaler and a metered-dose inhaler.
    Gillespie M, Song S, Steinfeld J.
    Allergy Asthma Proc; 2015 Mar; 36(5):365-71. PubMed ID: 26314817
    [Abstract] [Full Text] [Related]

  • 19. Significant variability in response to inhaled corticosteroids for persistent asthma.
    Szefler SJ, Martin RJ, King TS, Boushey HA, Cherniack RM, Chinchilli VM, Craig TJ, Dolovich M, Drazen JM, Fagan JK, Fahy JV, Fish JE, Ford JG, Israel E, Kiley J, Kraft M, Lazarus SC, Lemanske RF, Mauger E, Peters SP, Sorkness CA, Asthma Clinical Research Network of the National Heart Lung, and Blood Institute.
    J Allergy Clin Immunol; 2002 Mar; 109(3):410-8. PubMed ID: 11897984
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the clinical effects of combined salmeterol/fluticasone delivered by dry powder or pressurized metered dose inhaler.
    Hojo M, Shirai T, Hirashima J, Iikura M, Sugiyama H.
    Pulm Pharmacol Ther; 2016 Apr; 37():43-8. PubMed ID: 26898348
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.